Table 3.
Screening of diabetes-related complications in patients with diabetes mellitus
| Screening for any diabetes-related complication, n (%) | |
| Yes | 553 (97.9) |
| No | 12 (2.1) |
| Screening for cardiovascular disease | |
| At least one time during the past year | 376 (76.9) |
| Never | 113 (23.1) |
| Eye screening | |
| At least one time during the past year | 295 (65.7) |
| Never | 154 (34.3) |
| Number of eye screening, mean (SD) | 1.20 (0.57) |
| Screening for nerve damage | |
| At least one time during the past year | 232 (53.8) |
| Never | 199 (46.2) |
| Number of screening for nerve damage, mean ± SD | 1.75 ± 1.01 |
| Screening for kidney damage | |
| At least one time during the past year | 425 (82.5) |
| Never | 90 (17.5) |
| Number of screening for kidney damage, mean ± SD | 1.87 ± 1.02 |
| Screening for foot examination | |
| At least one time during the past year | 297 (63.9) |
| Never | 168 (36.1) |
| Number of screening for foot examination, mean ± SD | 1.90 ± 1.08 |
| Screening for blood lipid control | |
| At least one time during the past year | 496 (94.8) |
| Never | 27 (5.2) |
| Number of screening for blood lipid control, mean ± SD | 2.06 ± 1.04 |
| Screening for blood pressure control n (%) | |
| At least one time during the past year | 286 (86.1) |
| Never | 46 (13.9) |
| Number of screening for blood pressure control, mean ± SD | 2.57 ± 1.17 |